Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic DNA Methylation Markers for Prostate Cancer

18 Sept 2014

Abstract excerpt

Prostate cancer (PC) is the most commonly diagnosed neoplasm and the third most common cause of cancer-related death amongst men in the Western world. PC is a clinically highly heterogeneous disease, and distinction between aggressive and indolent disease is a major challenge for the management of PC. Currently, no biomarkers or prognostic tools are able to accurately predict tumor progression at the time of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25238417
DOI: 10.3390/ijms150916544

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic DNA Methylation Markers for Prostate CancerPMID 25238417Read ↗

Advances in Prognostic Methylation Biomarkers for Prostate CancerSemantic proximity Read ↗

Advances in Prognostic Methylation Biomarkers for Prostate CancerSemantic proximity Read ↗

DNA methylation alterations in prostate cancer: from diagnosis to treatmentSemantic proximity Read ↗

Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate CancerSemantic proximity Read ↗

Epigenetic biomarkers in prostate cancer: Current and future uses.Semantic proximity Read ↗

Prediction of Prognosis in Patients with Prostate Cancer by DNA Methylation ClassificationSemantic proximity Read ↗

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate CancerSemantic proximity Read ↗

Identification of Methylation Biomarkers for Early Detection of Prostate CancerSemantic proximity Read ↗

Epigenetic Markers for Molecular Detection of Prostate CancerSemantic proximity Read ↗

Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate CancerSemantic proximity Read ↗

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortalitySemantic proximity Read ↗

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.